Description
In this issue of Urologic Clinics of North America, guest editors Drs. Michael L. Blute and Steven L. Chang bring their considerable expertise to the topic of Renal Cancer: Old and New Paradigms. Recent significant advances in the management of renal cancer have expanded beyond simply eliminating disease to preserving and optimizing quality of life. In this issue, top experts highlight historical perspectives as well as current status and future treatments of renal cancer.- Contains 13 practice-oriented topics on biomarkers for the detection and surveillance of renal cancer; the changing role of renal mass biopsy; renal cysts: an oncological conundrum; the surgical management of renal cancer with inferior vena caval thrombus; integrating surgery in the multidisciplinary care of advanced renal cancer; and more.- Provides in-depth clinical reviews on renal cancer, offering actionable insights for clinical practice.- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Table of Contents
Radiologist's Disease: Imaging for Renal CancerEvolution in the Pathologic Classification of Renal NeoplasiaBiomarkers for the Detection and Surveillance of Renal CancerDiseases of Hereditary Renal Cell CancersThe Changing Role of Renal Mass BiopsyCystic Renal Masses: Old and New ParadigmsLong-Term Renal Function Following Renal Cancer Surgery: Historical Perspectives, Current Status, and Future ConsiderationsSurgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor ThrombusThe Promise of Neoadjuvant and Adjuvant Therapies for Renal CancerThe Great Masquerader's New Wardrobe in the Modern Era: The Paraneoplastic Manifestations of Renal CancerIntegrating Surgery in the Multidisciplinary Care of Advanced Renal Cell CarcinomaRadiation Therapy in the Treatment of Localized and Advanced Renal CancerThe Changing Landscape of Immunotherapy for Advanced Renal Cancer
